Skip to main content

Find Clinical Trials

Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,018 public trials 2,029 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Non-Interventional Study to Examine Rituximab Treatment in Follicular Lymphoma Participants

NCT02536664

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Essen, Germany

View Trial Details

Completed

Phase III Study of SyB L-0501 in Combination With Rituximab to Treat Recurrent/Relapsed Diffuse Large B-Cell Lymphoma

NCT03372837

Conditions: Assess the Efficacy and Safety of SyB L-0501 in Combination With Rituximab in Patients With Recurrent or Relapsed DLBCL, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Research Site Nagoya, Aichi-ken, Japan

Research Site Toyoake, Aichi-ken, Japan

Research Site Matsuyama, Ehime, Japan

Research Site Maebashi, Gunma, Japan

View all 29 locations

View Trial Details

Completed

Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma Gait Parameters Study

NCT01565447

Conditions: Acute Lymphoblastic Leukemia, Childhood Lymphoblastic Lymphoma, Hematologic Diseases, +10 more
Locations: Doernbecher Children Hospital Portland, Oregon, United States

View Trial Details

Completed

Impact of the Qatar 2022 FIFA World Cup on PED Use and Misuse Patterns

NCT05818215

Conditions: Disease Attributes, Electronic Medical Record, Emergencies, +22 more
Locations: Geneva Children's Hospital Geneva, Switzerland

View Trial Details

Completed

Clinical Trial to Evaluate CD19 CAR T (CT032) in Patients With Relapsed and/or Refractory Non-Hodgkin's B Cell Lymphoma

NCT03994913

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine Shanghai, Shanghai Municipality, China

First Affiliated Hospital of Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Completed

A Study of Subcutaneous Delivery of JNJ-54767414 (Daratumumab) in Japanese Participants With Relapsed or Refractory Multiple Myeloma

NCT03242889

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: National Hospital Organization Shibukawa Medical Center Gunma, Japan

Nagoya City University Hospital Nagoya, Japan

Ogaki Municipal Hospital Ohgaki, Japan

Osaka University Hospital Osaka, Japan

View Trial Details

Completed

Endothelial Function and IMT in Survivors of Hodgkin's Lymphoma

NCT00428688

Conditions: Cardiovascular Diseases, Hemic and Lymphatic Diseases, Hodgkin Disease, +8 more
Locations: The Endothelaial function lab, The Heart Institute, Sheba Medical Center, Israel Ramat Gan, Israel

View Trial Details

Completed

Management of FI After Surgery of ARM

NCT05621629

Conditions: Anorectal Malformations, Childhood ALL, Congenital Abnormalities, +18 more
Locations: Shengjing Hospital Shenyang, Liaoning, China

View Trial Details

Completed

The Influence of Food for Special Dietary Use - Spread Enriched With 5-hydroxytryptophan, Theanine and Gamma-aminobutyric Acid on Psychophysiological Functions of Subjects Without Meaningful Organic and Cognitive Pathology

NCT05543811

Conditions: Behavior, Cognitive Change, Concentration Ability Impaired, +14 more
Locations: Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology Moscow, Russia

View Trial Details

Completed

Study Evaluating ABT-199 in Participants With Relapsed or Refractory Multiple Myeloma

NCT01794520

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Mayo Clinic - Scottsdale /ID# 75808 Scottsdale, Arizona, United States

University of Arkansas for Medical Sciences /ID# 170002 Little Rock, Arkansas, United States

Yale University /ID# 203704 New Haven, Connecticut, United States

Emory University, Winship Cancer Institute /ID# 74993 Atlanta, Georgia, United States

View all 29 locations

View Trial Details